. Author manuscript; available in PMC: 2017 Jun 27.

Published in final edited form as: Am J Hematol. 2016 Feb;91(2):227–232. doi: 10.1002/ajh.24252

TABLE VII.

Multivariate Analysis for Survival in Patients Age 60–69 Years.

	HR	95% CI	P value
Poor risk cytogenetics	2.18	1.72–2.76	<0.0005
Therapy-related	1.55	1.19–2.02	0.001
Peripheral blasts	1.54	1.18–2.0	0.001
LDH	1.34	1.07–1.67	0.010
Marrow blasts	0.72	0.49–1.05	0.08
20–29%
Marrow blasts ≥30%	1.05	0.79–1.41	0.72
WBC ≥25 (×10⁹/l)	1.22	0.90–1.66	0.20
Other intermediate cytogenetics	1.04	0.78–1.40	0.77